The global vascular interventional devices market consist of devices used in both coronary and peripheral endovascular procedures which includes balloons, EVAR stent grafts, IVC filters, IVUS & angiography catheters, plaque modification devices, hemodynamic flow alteration devices and accessory devices. This Interventional Cardiology Devices Market was valued at $8.7 billion in 2011 and is poised to grow at a CAGR of 7.8% to reach $12.7 billion by 2016. Moreover, the global stents market for coronary and peripheral procedures was valued at $16.0 billion in 2011 and is expected to grow at a CAGR of 9.5% to reach $25.2 billion by 2016.
A significant growth has been seen in the use of interventional endovascular procedures in the recent years, which is largely driven by healthcare, demographic, and cost-effective factors. The coronary and peripheral vascular markets together contribute to this growth in interventional procedures. The peripheral angioplasty procedures are expected to grow at a faster rate with a CAGR of 8.9% and is expected to reach 3.3 million procedures by 2016, while coronary angioplasty procedures will have a steady growth with a CAGR of 6.7% and estimated to reach 4.5 million procedures by 2016.
Explore Comprehensive list of Tables & Figures available in the report Cardiology Devices Market
Report Details:
Published: March 2012
No. of Pages: 471
Price: Single User License – US$6450 Corporate User License – US$7150
North America will be the biggest market for vascular interventional devices, followed by Europe. However, Asian countries represent the fastest growing markets as low procedural and infrastructural costs have led to an increased drive of patients from developed regions towards Asian countries such as India and China. Moreover, established players in the market such as Abbott Vascular (U.S.), Boston Scientific (U.S.) and Medtronic Inc. (U.S.) have shown an increased inclination towards Asian countries for market expansion.
Major players in the market include Abbott Vascular, Boston Scientific, Medtronic Inc., C.R. Bard Inc. (U.S.), B Braun Inc. (Germany), Cook Medical (U.S.), Cordis Corp. (U.S.), St. Jude Medical (U.S.), Teleflex Medical (U.S.), Terumo Interventional Systems Inc. (Japan), Bayer, Edward Lifesciences, Covidien (Ireland), Endologix (U.S.), W.L.Gore & Associates Ltd. (U.S.), Volcano Corporation (U.S.), Angioscore Ltd. (U.S.) among others..
Major points covered in Table of Contents of this report include
1 INTRODUCTION
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
4 ANGIOPLASTY PROCEDURES
5 ANGIOPLASTY BALLOONS
6 ANGIOPLASTY STENTS
7 CATHETERS
8 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET
9 INFERIOR VENA CAVA (IVC) FILTERS MARKET
10 PLAQUE MODIFICATION DEVICES MARKET
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET
12 ACCESSORY DEVICES
13 GEOGRAPHIC ANALYSIS
14 COMPETITIVE LANDSCAPE
15 COMPANY PROFILES
List Of Tables
Browse here for all Cardiovascular Research Reports
A significant growth has been seen in the use of interventional endovascular procedures in the recent years, which is largely driven by healthcare, demographic, and cost-effective factors. The coronary and peripheral vascular markets together contribute to this growth in interventional procedures. The peripheral angioplasty procedures are expected to grow at a faster rate with a CAGR of 8.9% and is expected to reach 3.3 million procedures by 2016, while coronary angioplasty procedures will have a steady growth with a CAGR of 6.7% and estimated to reach 4.5 million procedures by 2016.
Explore Comprehensive list of Tables & Figures available in the report Cardiology Devices Market
Report Details:
Published: March 2012
No. of Pages: 471
Price: Single User License – US$6450 Corporate User License – US$7150
North America will be the biggest market for vascular interventional devices, followed by Europe. However, Asian countries represent the fastest growing markets as low procedural and infrastructural costs have led to an increased drive of patients from developed regions towards Asian countries such as India and China. Moreover, established players in the market such as Abbott Vascular (U.S.), Boston Scientific (U.S.) and Medtronic Inc. (U.S.) have shown an increased inclination towards Asian countries for market expansion.
Major players in the market include Abbott Vascular, Boston Scientific, Medtronic Inc., C.R. Bard Inc. (U.S.), B Braun Inc. (Germany), Cook Medical (U.S.), Cordis Corp. (U.S.), St. Jude Medical (U.S.), Teleflex Medical (U.S.), Terumo Interventional Systems Inc. (Japan), Bayer, Edward Lifesciences, Covidien (Ireland), Endologix (U.S.), W.L.Gore & Associates Ltd. (U.S.), Volcano Corporation (U.S.), Angioscore Ltd. (U.S.) among others..
Major points covered in Table of Contents of this report include
1 INTRODUCTION
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
4 ANGIOPLASTY PROCEDURES
5 ANGIOPLASTY BALLOONS
6 ANGIOPLASTY STENTS
7 CATHETERS
8 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET
9 INFERIOR VENA CAVA (IVC) FILTERS MARKET
10 PLAQUE MODIFICATION DEVICES MARKET
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET
12 ACCESSORY DEVICES
13 GEOGRAPHIC ANALYSIS
14 COMPETITIVE LANDSCAPE
15 COMPANY PROFILES
List Of Tables
Browse here for all Cardiovascular Research Reports
No comments:
Post a Comment